Wed. 6 Mar 2024, 4:19pm ET
Benzinga
Earnings, Earnings Misses, News
Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.770) per share which missed the analyst consensus estimate of $(0.190) by 305.26 percent. The company reported quarterly sales of $276.600 million which missed the analyst consensus estimate of $293.533 million by 5.77 percent. This is a 16.36 percent decrease over sales of $330.700 million the same period last year.